Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism CHRNA6 modulators(cholinergic receptor nicotinic alpha 6 subunit modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Cerevance, Inc.Startup |
Active Organization- |
Inactive Organization Cerevance, Inc.Startup |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H23ClN4O2 |
InChIKeyQLOHOGRMRUDDPM-GFCCVEGCSA-N |
CAS Registry2919851-74-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinson Disease | Preclinical | US | Cerevance, Inc.Startup | 20 Mar 2023 |